Present Treatment Options for Atrial Fibrillation
Atrial fibrillation affects almost 60 million adults worldwide. Atrial fibrillation is linked to an increased risk of cardiovascular morbidity and death as well as social, psychological, and financial costs on patients and their families. In the examination, treatment, and management of atrial fibrillation, socioeconomic variables such as race and ethnicity, financial resources, social support, access to health care, reality and residential environment, local language competence, and health literacy play important roles. Reducing the significant clinical and non-clinical difficulties associated with atrial fibrillation requires addressing the socioeconomic determinants of health. The contributions of social variables on the patient experience and outcomes associated with this common ailment are summarized in this review. The importance of socioeconomic variables and their critical confluence with atrial fibrillation therapy and outcomes is highlighted. Finally, we point out gaps in the literature and suggest future research objectives for social determinants and atrial fibrillation.